Automatic Insulin Pumps in Pregnancy: What the Evidence Shows

Pregnancy brings significant changes to insulin needs and blood sugar management for women with Type 1 diabetes. Keeping blood sugar levels as close to target as possible during pregnancy is important for reducing risks like fetal overgrowth—a condition where the baby grows larger than expected. At the same time, avoiding low blood sugar episodes is critical for both mother and baby.

More women with Type 1 diabetes are now using automatic insulin pump systems—devices that continuously deliver insulin and adjust doses based on blood sugar readings. Researchers wanted to understand how these systems perform during and after pregnancy compared to other insulin delivery methods.

The review found that pregnant women using automatic insulin pumps achieved blood sugar levels that stayed closer to their target range than women using insulin pens or manual pumps. This tighter control is important because it reduces pregnancy-related risks.

Another key finding: women on automatic pumps experienced fewer episodes of low blood sugar during pregnancy. Hypoglycemia—especially severe low blood sugar—can be dangerous for both mother and developing baby, so this is a meaningful benefit.

Despite the benefits in blood sugar control, the research found that gestational weight gain—the amount of weight gained during pregnancy—was similar across all three delivery methods: automatic pumps, insulin pens, and manual pumps.

Most importantly, fetal overgrowth occurred at similar rates regardless of which insulin delivery system a woman used. This suggests that the type of pump or insulin device matters less than overall blood sugar control. In other words, achieving and maintaining target blood sugar levels is the critical factor for reducing fetal overgrowth risk, not the device itself.

This research supports what was already known: automatic insulin pumps help improve glucose control outside of pregnancy. The new insight is that these benefits extend into pregnancy—women can achieve better blood sugar targets with fewer low episodes.

However, the findings also show that no single insulin delivery system eliminates the risk of pregnancy complications on its own. The focus remains on achieving strict glucose control, regardless of whether that's done with an automatic pump, insulin pen, or manual pump. Women with Type 1 diabetes who are pregnant or planning pregnancy should work closely with their healthcare team to find the insulin delivery method that works best for their individual needs and circumstances.

Source: Ugeskrift for laeger. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.